In pathological conditions, such as AD, astrocytes undergo reactive astrogliosis, identified by overexpression of glial fibrillary acidic protein (GFAP) and vimentin in post-mortem tissues from AD patients and mouse models [37,38]. The gene discussed is GFAP; the disease is Alzheimer disease.